Potential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment Costs  Eduardo Lacson, MD, T. Alp Ikizler, MD, J. Michael Lazarus, MD, Ming Teng, MD, Raymond M. Hakim, MD  Journal of Renal Nutrition  Volume 17, Issue 6, Pages 363-371 (November 2007) DOI: 10.1053/j.jrn.2007.08.009 Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Projected distribution shift of the patient population resulting from a hypothetical systematic intervention with a +0.2 g/dL improvement in serum albumin in 50% of patients (base case). Only patients in albumin categories of ≤3.50 g/dL were projected to be reassigned to the higher albumin category, whereas the two categories between 3.51 and 3.70 g/dL were projected to receive some of those patients who improved. Journal of Renal Nutrition 2007 17, 363-371DOI: (10.1053/j.jrn.2007.08.009) Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Association between mean serum albumin level in the fourth quarter of 2003 with (a) mortality risk and (b) hospitalization risk during 2004, each shown with results from unadjusted, case-mix (CM)-adjusted, and fully adjusted models. Journal of Renal Nutrition 2007 17, 363-371DOI: (10.1053/j.jrn.2007.08.009) Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Change in mean serum albumin level (first vs. fourth quarter of 2003) in the patient subset that started the first quarter of 2003 at a mean serum albumin of ≤3.5 g/dL, and the association with (a) mortality risk and (b) hospitalization risk during 2004, each shown with results from unadjusted, case-mix (CM)-adjusted, and fully adjusted models. Journal of Renal Nutrition 2007 17, 363-371DOI: (10.1053/j.jrn.2007.08.009) Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions